Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

242 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Sequential dose-dense doxorubicin and ifosfamide for advanced soft tissue sarcomas: a Phase II trial by the Spanish Group for Research on Sarcomas (GEIS).
Maurel J, Fra J, López-Pousa A, García del Muro X, Balañá C, Casado A, Martín J, Martínez-Trufero J, de las Peñas R, Buesa JM; Spanish Group for Research on Sarcomas (GEIS). Maurel J, et al. Cancer. 2004 Apr 1;100(7):1498-506. doi: 10.1002/cncr.20115. Cancer. 2004. PMID: 15042685 Free article. Clinical Trial.
Efficacy of sequential high-dose doxorubicin and ifosfamide compared with standard-dose doxorubicin in patients with advanced soft tissue sarcoma: an open-label randomized phase II study of the Spanish group for research on sarcomas.
Maurel J, López-Pousa A, de Las Peñas R, Fra J, Martín J, Cruz J, Casado A, Poveda A, Martínez-Trufero J, Balañá C, Gómez MA, Cubedo R, Gallego O, Rubio-Viqueira B, Rubió J, Andrés R, Sevilla I, de la Cruz JJ, Del Muro XG, Buesa JM. Maurel J, et al. J Clin Oncol. 2009 Apr 10;27(11):1893-8. doi: 10.1200/JCO.2008.19.2930. Epub 2009 Mar 9. J Clin Oncol. 2009. PMID: 19273704 Clinical Trial.
Phase II, randomized study of concomitant chemoradiotherapy followed by surgery and adjuvant capecitabine plus oxaliplatin (CAPOX) compared with induction CAPOX followed by concomitant chemoradiotherapy and surgery in magnetic resonance imaging-defined, locally advanced rectal cancer: Grupo cancer de recto 3 study.
Fernández-Martos C, Pericay C, Aparicio J, Salud A, Safont M, Massuti B, Vera R, Escudero P, Maurel J, Marcuello E, Mengual JL, Saigi E, Estevan R, Mira M, Polo S, Hernandez A, Gallen M, Arias F, Serra J, Alonso V. Fernández-Martos C, et al. Among authors: maurel j. J Clin Oncol. 2010 Feb 10;28(5):859-65. doi: 10.1200/JCO.2009.25.8541. Epub 2010 Jan 11. J Clin Oncol. 2010. PMID: 20065174 Clinical Trial.
[Recommendations for diagnosis, staging and treatment of pancreatic cancer (Part I). Grupo Español de Consenso en Cáncer de Páncreas].
Navarro S, Vaquero E, Maurel J, Bombí JA, De Juan C, Feliu J, Fernández Cruz L, Ginés A, Girela E, Rodríguez R, Sabater L; Representación del Grupo Español de Consenso en Cáncer de Páncreas; Club Español Biliopancreático (CEBP); Grupo Español Multidisciplinar de Cáncer Digestivo (GEMCAD); Sociedad Española de Diagnóstico por Imagen del Abdomen (SEDIA); Sociedad Española de Endoscopia Digestiva (SEED); Sociedad Española de Anatomía Patológica (SEAP). Navarro S, et al. Among authors: maurel j. Med Clin (Barc). 2010 May 15;134(14):643-55. doi: 10.1016/j.medcli.2009.12.014. Epub 2010 Mar 26. Med Clin (Barc). 2010. PMID: 20346471 Spanish. No abstract available.
[Recommendations for diagnosis, staging and treatment of pancreatic cancer (Part II)].
Navarro S, Vaquero E, Maurel J, Bombí JA, De Juan C, Feliu J, Fernández Cruz L, Ginés A, Girela E, Rodríguez R, Sabater L; en representación del Grupo Español de Consenso en Cáncer de Páncreas; el Club Español Biliopancreático (CEBP); Grupo Español Multidisciplinar de Cáncer Digestivo (GEMCAD); Sociedad Española de Diagnóstico por Imagen del Abdomen (SEDIA); Sociedad Española de Endoscopia Digestiva (SEED); la Sociedad Española de Anatomía Patológica (SEAP). Navarro S, et al. Among authors: maurel j. Med Clin (Barc). 2010 May 22;134(15):692-702. doi: 10.1016/j.medcli.2010.01.006. Epub 2010 Mar 30. Med Clin (Barc). 2010. PMID: 20356609 Spanish. No abstract available.
Co-expression of matrix metalloproteinase-7 (MMP-7) and phosphorylated insulin growth factor receptor I (pIGF-1R) correlates with poor prognosis in patients with wild-type KRAS treated with cetuximab or panitumumab: a GEMCAD study.
Hörndler C, Gallego R, García-Albeniz X, Alonso-Espinaco V, Alonso V, Escudero P, Jimeno M, Ortego J, Codony-Servat J, Fernández-Martos C, Calatrava A, Marín-Aguilera M, Muñoz J, Castellví-Bel S, Castells A, Rubini M, Gascón P, Maurel J. Hörndler C, et al. Among authors: maurel j. Cancer Biol Ther. 2011 Jan 15;11(2):177-83. doi: 10.4161/cbt.11.2.13839. Epub 2011 Jan 15. Cancer Biol Ther. 2011. PMID: 21099348 Free article.
Serum matrilysin correlates with poor survival independently of KRAS and BRAF status in refractory advanced colorectal cancer patients treated with irinotecan plus cetuximab.
Garcia-Albeniz X, Pericay C, Alonso-Espinaco V, Alonso V, Escudero P, Fernández-Martos C, Gallego R, Gascón P, Castellví-Bel S, Maurel J. Garcia-Albeniz X, et al. Among authors: maurel j. Tumour Biol. 2011 Apr;32(2):417-24. doi: 10.1007/s13277-010-0136-3. Epub 2010 Nov 23. Tumour Biol. 2011. PMID: 21104178
Design and endpoints of clinical and translational trials in advanced colorectal cancer. a proposal from GROUP Español Multidisciplinar en Cancer Digestivo (GEMCAD).
Carrera G, Garcia-Albeniz X, Ayuso JR, Aparicio J, Castells A, Codony-Servat J, Feliu J, Fuster D, Gallego R, Pagés M, Torres F, Maurel J. Carrera G, et al. Among authors: maurel j. Rev Recent Clin Trials. 2011 May;6(2):158-70. doi: 10.2174/157488711795177868. Rev Recent Clin Trials. 2011. PMID: 21241233 Review.
242 results